Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 102.23% | -33.60% | -45.78% | 1.48% | 36.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 102.23% | -33.60% | -45.78% | 1.48% | 36.80% |
| Cost of Revenue | 18.41% | -32.70% | -22.84% | -12.89% | 1.02% |
| Gross Profit | 172.21% | -34.00% | -58.71% | 7.70% | 94.78% |
| SG&A Expenses | 64.24% | -27.84% | -2.07% | -18.21% | 4.93% |
| Depreciation & Amortization | -100.00% | -- | -- | 60.41% | 1.51% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.71% | -35.57% | -16.76% | -9.06% | 3.48% |
| Operating Income | 70.76% | 39.51% | -18.58% | 42.80% | 25.46% |
| Income Before Tax | 51.49% | 49.94% | -15.12% | 27.86% | 15.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 51.49% | 49.94% | -15.12% | 27.86% | 15.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.49% | 49.94% | -15.12% | 27.86% | 15.84% |
| EBIT | 70.76% | 39.51% | -18.58% | 42.80% | 25.46% |
| EBITDA | 61.05% | 16.21% | -55.95% | 118.66% | 39.14% |
| EPS Basic | 52.94% | 50.00% | -14.29% | 33.33% | 15.00% |
| Normalized Basic EPS | 50.00% | 50.00% | -11.11% | 25.00% | 16.67% |
| EPS Diluted | 52.94% | 50.00% | -14.29% | 33.33% | 15.00% |
| Normalized Diluted EPS | 50.00% | 50.00% | -11.11% | 25.00% | 16.67% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |